Antibody Therapeutics for Life

Press Release


No Title Written by Written date Inquire
7   PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting   PharmAbcine   2020-04-06   20,300  
6   PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial   PharmAbcine   2019-11-20   17,408  
5   PharmAbcine,BioPharma Dealmakers_sep 2019   PharmAbcine   2019-10-01   15,610  
4   PharmAbcine, Drug Discovery Special APAC 2019   PharmAbcine   2019-09-17   19,814  
3   PharmAbcine, HREC Approval announcement Austin Health   PharmAbcine   2019-08-23   17,220  
2   PharmAbcine Appoints Legendary Pathologist Dr. David Cheresh to Scientific Advisory Board   Admin   2019-03-07   34,240  
1   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with PHARMA   Admin   2019-03-05   12,620